--News Direct--
Although Black Americans have the same rate of bipolar disorder as other racial and ethnic groups, they are less likely to receive a diagnosis due to lack of access and cultural stigma. Check out the facts and consider sharing this resource with a friend: https://mhanational.org/bipolar-disorder-and-black-americans?sf167604932=1
About Alkermes
Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com .
View additional multimedia and more ESG storytelling from Alkermes on 3blmedia.com
View source version on newsdirect.com: https://newsdirect.com/news/why-are-some-black-americans-with-bipolar-disorder-going-undiagnosed-870502295